Stanley R. Riddell

49.3k citations

303 papers · 34.0k indexed · 22 hit papers · h-index 98

Oncology top 0.01%
Immunology top 0.02%
Molecular Biology top 0.5%
Genetics top 0.05%
Epidemiology top 0.1%

Co-authors: Philip D. Greenberg Cameron J. Turtle Michael C. Jensen Edus H. Warren David G. Maloney Carolina Berger Daniel Sommermeyer Michael Hudecek
Topics: CAR-T cell therapy research (177 papers)Immune Cell Function and Interaction (110 papers)Immunotherapy and Immune Responses (74 papers)
Cited by: Immunology Oncology Hematology
Journals: Nature Science New England Journal of Medicine
Partner nations: United States South Africa Germany

In The Last Decade

Stanley R. Riddell

296 papers receiving 33.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

1995 1.5k citations Philip D. Greenberg, Stanley R. Riddell et al. profile →
Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones

1992 1.0k citations Stanley R. Riddell, Philip D. Greenberg et al. Science profile →
Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

2017 948 citations Juliane Gust, Kevin A. Hay et al. Cancer Discovery profile →
Adoptive T cell therapy using antigen-specific CD8⁺T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells

2002 941 citations Cassian Yee, Stanley R. Riddell et al. Proceedings of the National Academy of Sciences profile →
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells

2001 803 citations Veronika Groh, Julie Randolph‐Habecker et al. profile →
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

2017 787 citations Marie Bleakley, Catherine Lindgren et al. Blood profile →
Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells

2009 780 citations Cameron J. Turtle, Stanley R. Riddell et al. Blood profile →
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy

2017 775 citations Kevin A. Hay, Laïla‐Aïcha Hanafi et al. Blood profile →
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 ⁺ and CD4 ⁺ CD19-specific chimeric antigen receptor–modified T cells

2016 741 citations Cameron J. Turtle, Laïla‐Aïcha Hanafi et al. profile →
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

2008 654 citations Carolina Berger, Michael C. Jensen et al. profile →
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo

2015 639 citations Daniel Sommermeyer, Michael Hudecek et al. profile →
Therapeutic T cell engineering

2017 628 citations Stanley R. Riddell et al. profile →
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

2008 573 citations Brian G. Till, Michael C. Jensen et al. Blood profile →
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy

2016 544 citations Michael C. Jensen, Stanley R. Riddell et al. Blood profile →
Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib

2017 485 citations Cameron J. Turtle, Kevin A. Hay et al. profile →
A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells

2011 472 citations Stephen J. Forman, Stanley R. Riddell et al. Blood profile →
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

2012 431 citations Brian G. Till, Michael C. Jensen et al. Blood profile →
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity

2014 406 citations Michael Hudecek, Daniel Sommermeyer et al. Cancer Immunology Research profile →
Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy

2017 391 citations Joshua A. Hill, Daniel Li et al. Blood profile →
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

2022 297 citations Stanley R. Riddell et al. profile →
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure

2020 227 citations Kevin A. Hay, Cecilia C.S. Yeung et al. Blood profile →
Designed protein logic to target cells with precise combinations of surface antigens

2020 144 citations Alexander I. Salter, Anusha Rajan et al. Science profile →

Peers

Countries citing papers authored by Stanley R. Riddell

Since Specialization

Citations

This map shows the geographic impact of Stanley R. Riddell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley R. Riddell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley R. Riddell more than expected).

Fields of papers citing papers by Stanley R. Riddell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley R. Riddell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley R. Riddell. The network helps show where Stanley R. Riddell may publish in the future.

Co-authorship network of co-authors of Stanley R. Riddell

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley R. Riddell. A scholar is included among the top collaborators of Stanley R. Riddell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley R. Riddell. Stanley R. Riddell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia 2021 ·Clinical Cancer Research ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Shivani Srivastava,(unknown),Jenny L. Smith,Amanda R. Leonti,Rhonda E. Ries,Laura Pardo,Michael R. Loken,Colin Correnti,(unknown),Cameron J. Turtle,Stanley R. Riddell,Katherine Tarlock,Soheil Meshinchi	17
2	Infectious Complications and Humoral Immunity after BCMA-Directed Chimeric Antigen Receptor T-Cell Therapy in Adults with Multiple Myeloma 2021 ·Transplantation and Cellular Therapy ·Srirama Josyula,Margot J. Pont,(unknown),Xiaoling Song,Sushma Thomas,Gregory Pepper,Elizabeth M. Krantz,Stanley R. Riddell,Andrew J. Cowan,Damian J. Green,Joshua A. Hill	2
3	Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors 2019 ·Clinical Cancer Research ·Ashwini Balakrishnan,Anusha Rajan,Alexander I. Salter,Paula L. Kosasih,Qian Wu,Jenna Voutsinas,Michael C. Jensen,Andreas Plückthun,Stanley R. Riddell	48
4	Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 ( Her2 ) Driver Mutations 2019 ·Cancer Immunology Research ·Joshua Veatch,(unknown),Julia Kargl,Matthew Fitzgibbon,Sylvia M. Lee,Christina S. Baik,Renato Martins,A. McGarry Houghton,Stanley R. Riddell	70
5	Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cellsbreakdown → 2017 ·Cancer Discovery ·Juliane Gust,Kevin A. Hay,Laïla‐Aïcha Hanafi,Daniel Li,David Myerson,Luis F. Gonzalez‐Cuyar,Cecilia C.S. Yeung,W. Conrad Liles,(unknown),José A. López,Junmei Chen,Dominic W. Chung,Susanna Harju-Baker,Tahsin Özpolat,Kathleen R. Fink,Stanley R. Riddell,David G. Maloney,Cameron J. Turtle	948
6	Preserved Activity of CD20-Specific Chimeric Antigen Receptor–Expressing T Cells in the Presence of Rituximab 2016 ·Cancer Immunology Research ·(unknown),Oliver W. Press,Philip Olsen,Sang Yun Lee,Michael C. Jensen,Ajay K. Gopal,Barbara Pender,Lihua E. Budde,(unknown),Damian J. Green,David G. Maloney,Stanley R. Riddell,Brian G. Till	22
7	Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues 2016 ·Clinical Cancer Research ·Ashwini Balakrishnan,Tracy Goodpaster,Julie Randolph‐Habecker,Benjamin G. Hoffstrom,Florencia G. Jalikis,Lisa Koch,Carolina Berger,Paula L. Kosasih,Anusha Rajan,Daniel Sommermeyer,Peggy L. Porter,Stanley R. Riddell	151
8	Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor–Modified T Cells 2014 ·Cancer Immunology Research ·Carolina Berger,Daniel Sommermeyer,Michael Hudecek,Michael Berger,Ashwini Balakrishnan,Paulina J. Paszkiewicz,Paula L. Kosasih,Christoph Rader,Stanley R. Riddell	139
9	The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activitybreakdown → 2014 ·Cancer Immunology Research ·Michael Hudecek,Daniel Sommermeyer,Paula L. Kosasih,Anne Silva-Benedict,Lingfeng Liu,Christoph Rader,Michael C. Jensen,Stanley R. Riddell	406
10	Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells 2013 ·Clinical Cancer Research ·Michael Hudecek,Maria Teresa Lupo Stanghellini,Paula L. Kosasih,Daniel Sommermeyer,Michael C. Jensen,Christoph Rader,Stanley R. Riddell	424
11	CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsbreakdown → 2012 ·Blood ·Brian G. Till,Michael C. Jensen,Jinjuan Wang,Xiaojun Qian,Ajay K. Gopal,David G. Maloney,Catherine Lindgren,Yukang Lin,John M. Pagel,Lihua E. Budde,Andrew Raubitschek,Stephen J. Forman,Philip D. Greenberg,Stanley R. Riddell,Oliver W. Press	431
12	Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells 2010 ·Blood ·Marie Bleakley,Brith Otterud,(unknown),(unknown),Michael Hudecek,Tetsuya Nishida,Colette Chaney,Edus H. Warren,Mark Leppert,Stanley R. Riddell	79
13	Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+ Cytolytic T Cells 2009 ·Cancer Research ·Christine E. Brown,Renate Starr,Catalina Martínez,Brenda Aguilar,Massimo D’Apuzzo,Иван Тодоров,(unknown),Behnam Badie,Michael Hudecek,Stanley R. Riddell,Michael C. Jensen	113
14	Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus 2009 ·The Journal of Experimental Medicine ·Zhenpeng Dai,Cameron J. Turtle,Garrett C. Booth,Stanley R. Riddell,Theodore A. Gooley,Anne M. Stevens,Thomas A. Spies,Veronika Groh	97
15	Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia 2009 ·Clinical Cancer Research ·Tetsuya Nishida,Michael Hudecek,Ana Kostić,Marie Bleakley,Edus H. Warren,David G. Maloney,Rainer Storb,Stanley R. Riddell	31
16	C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients 2008 ·Clinical Cancer Research ·Scott S. Tykodi,Nobuharu Fujii,Nathalie Vigneron,Sharon Lu,Jeffrey K. Mito,(unknown),Jeffrey Chou,Lilien N. Voong,John A. Thompson,Brenda M. Sandmaier,Peter Cresswell,Benoı̂t Van den Eynde,Stanley R. Riddell,Edus H. Warren	43
17	An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order 2006 ·Science ·Edus H. Warren,Nathalie Vigneron,Marc A. Gavin,Pierre G. Coulie,Vincent Stroobant,Alexandre Dalet,Scott S. Tykodi,(unknown),Jeffrey K. Mito,Stanley R. Riddell,Benoı̂t J. Van den Eynde	160
18	Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells 2005 ·Proceedings of the National Academy of Sciences ·Veronika Groh,(unknown),Daniel Cioca,Naomi Hunder,Wei Wang,Stanley R. Riddell,Cassian Yee,Thomas A. Spies	74
19	Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection 2004 ·Blood ·Thomas Manley,(unknown),Thomas R. Jones,Michael Boeckh,Helen P. Mutimer,Stanley R. Riddell	92
20	Restoration of CD28 Expression in CD28− CD8 + Memory Effector T Cells Reconstitutes Antigen-induced IL-2 Production 2003 ·The Journal of Experimental Medicine ·Max S. Topp,Stanley R. Riddell,Yoshiki Akatsuka,Michael C. Jensen,Joseph N. Blattman,Philip D. Greenberg	109

About Stanley R. Riddell

Stanley R. Riddell is a scholar working on Immunology, Oncology and Hematology, having authored 303 papers that have together received 34.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (177 papers), Immune Cell Function and Interaction (110 papers) and Immunotherapy and Immune Responses (74 papers). The work is most often cited by research in Immunology (16.1k citations), Oncology (20.5k citations) and Hematology (3.8k citations). Stanley R. Riddell has collaborated with scholars based in United States, South Africa and Germany. Frequent co-authors include Philip D. Greenberg, Cameron J. Turtle, Michael C. Jensen, Edus H. Warren, David G. Maloney, Carolina Berger, Daniel Sommermeyer, Michael Hudecek, M. Jean Gilbert and Shivani Srivastava. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact